Out-of-pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross-sectional, non-comparative, multicentre study
| Autor: | J. Shourick, Ziad Reguiai, Laurent Misery, Hervé Bachelez, E. Mahé, Carle Paul, Denis Jullien, Khaled Ezzedine, M.-A. Richard, R. Aubert, Charles Taieb, Julien Seneschal, Pascal Joly, G. de Pouvourville |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Cross-sectional study Psychological intervention Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences Psoriatic arthritis 0302 clinical medicine Internal medicine Psoriasis Health care medicine Humans 030212 general & internal medicine Reimbursement business.industry Middle Aged medicine.disease Infectious Diseases Cross-Sectional Studies Observational study Female France Health Expenditures business Psychosocial Delivery of Health Care |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 35(4) |
| ISSN: | 1468-3083 |
| Popis: | BACKGROUND In 2018 in France, overall mean health-related out-of-pocket (OOP) expenditures were 214.00€/year/patient. AIM To evaluate OOP expenditures for psoriasis patients in France. METHODOLOGY Observational, cross-sectional, non-comparative, multicentre study in 3000 patients with clinically confirmed psoriasis who responded to a specific digital questionnaire collecting demographic and socio-economic characteristics, assessing the 3 domains (severity, psychosocial impact and past history and interventions) of the patient's Simplified Psoriasis Index (sa-SPI) and expenditures to manage psoriasis, including OOP. Multivariate linear regression was conducted to search for factors associated with higher OOP. RESULTS In total, 2681 patients completed the questionnaire and, of those, 2562 provided clinically validated data. Overall, 60% were women; the mean age was 49.4 ± 14.8 years. 30% of the patients declared that they suffered from psoriatic arthritis. The final mean sa-SPI core was 10.86 ± 9.70. Of these 2562 patients, 243 (9.5%) had severe, 442 (17.3%) moderate and 1877 (73.3%) mild psoriasis. In addition, 932 (36.4%) patients reported facial involvement, 724 (28.25%) genital impairment and 1124 (43.8%) lesions on the limbs. Mean OOP expenditures to manage psoriasis per patient were 531.00€, 439.74€ ± 939.85€ for patients with mild, 791.06€ ± 1367.67€ with moderate and 1077.64€ ± 1680.14€ for patients with severe psoriasis. For patients with psoriasis in the genital area, the median amount of expenditures (251.17€; CI95% [138.35;363.99]) was significantly higher than that for the face (183.85€; CI95% [78.76;288.94]) or limbs (199.96€; CI95% [93.77;306.15); (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text